![Philippe Crine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Crine
Oprichter bij PreciThera, Inc.
Actieve functies van Philippe Crine
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Institut de recherches cliniques de Montréal
![]() Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Directeur/Bestuurslid | 15-12-2015 | - |
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Directeur/Bestuurslid | 26-05-2016 | - |
Operationeel Directeur | 26-05-2016 | - | |
Oprichter | 26-05-2016 | - |
Loopbaan van Philippe Crine
Eerdere bekende functies van Philippe Crine
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | - | - |
Opleiding van Philippe Crine
University of Montréal | Doctorate Degree |
Statistieken
Internationaal
Canada | 5 |
Operationeel
Founder | 2 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
Institut de recherches cliniques de Montréal
![]() Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Commercial Services |
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Health Technology |
- Beurs
- Insiders
- Philippe Crine
- Ervaring